U-CORT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover U-cort, and when can generic versions of U-cort launch?
U-cort is a drug marketed by Taro and is included in one NDA.
The generic ingredient in U-CORT is hydrocortisone acetate. There are sixty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.
Summary for U-CORT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 81 |
Formulation / Manufacturing: | see details |
DailyMed Link: | U-CORT at DailyMed |
Pharmacology for U-CORT
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for U-CORT
US Patents and Regulatory Information for U-CORT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | U-CORT | hydrocortisone acetate | CREAM;TOPICAL | 089472-001 | Jun 13, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |